Cargando…
Efficacy of Low-Dose Rituximab on Neuromyelitis Optica-Associated Optic Neuritis
Purpose: To prospectively investigate the efficacy and tolerance of low-dose rituximab (RTX) for the treatment of neuromyelitis optica-associated optic neuritis (NMO-ON). Methods: Optic Neuritis patients with seropositive aquaporin 4-antibody (AQP4-Ab) were diagnosed with NMO-ON and recruited for tr...
Autores principales: | Zhao, Shuo, Zhou, Huanfen, Xu, Quangang, Dai, Hong, Wei, Shihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129159/ https://www.ncbi.nlm.nih.gov/pubmed/34017301 http://dx.doi.org/10.3389/fneur.2021.637932 |
Ejemplares similares
-
An Experimental Model of Neuromyelitis Optica Spectrum Disorder–Optic Neuritis: Insights Into Disease Mechanisms
por: Soerensen, Sofie Forsberg, et al.
Publicado: (2021) -
Association of Circulating T Follicular Helper Cells With Idiopathic Optic Neuritis and Neuromyelitis Optica Spectrum Disorders
por: Wu, Qian, et al.
Publicado: (2021) -
Cytokines and chemokines expression in serum of patients with neuromyelitis optica
por: Ai, Nanping, et al.
Publicado: (2019) -
Comparison of Long-Term Use of Low Dose Rituximab and Mycophenolate Mofetil in Chinese Patients With Neuromyelitis Optica Spectrum Disorder
por: Lin, Jie, et al.
Publicado: (2022) -
Clinical Features and Visual Outcomes of Optic Neuritis in Chinese Children
por: Zhou, Huanfen, et al.
Publicado: (2016)